Translational research brings discoveries from the laboratory and preclinical studies to clinical trials and studies in humans.

The research could point to future therapeutic strategies that treat PF patients based on their individual stage of cellular and molecular remodeling.

They are among more than 3,500 ASCI members, 48 of whom are current, full-time faculty members of the Vanderbilt University School of Medicine.

IPF is one of the most common forms of pulmonary fibrosis, an interstitial lung disease characterized by the progressive accumulation of scar tissue (fibrosis) in the epithelial lining of the airways.

The center was created earlier this year to save the lives of patients waiting for a transplant and improve outcomes for patients after they receive a transplant.

The awards support research efforts to identify optimal approaches to improving health care and health outcomes for patients, families and the community.

Approximately 1% of the U.S. population — 2 million to 3 million adults — experience critical illness requiring the placement of a breathing tube each year.